We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > True North

News List

Bristol Myers Squibb presents data from True North trial of Zeposia (ozanimod) for ulcerative colitis expresspharma
October 12, 2020
Both primary and all key secondary efficacy endpoints showed statistically significant improvements with oral Zeposia versus placebo at Week 10 and Week 52.
Bristol Myers Squibb announces positive topline results from True North trial evaluating Zeposia in pharmaceutical-business-review
June 05, 2020
Bristol Myers Squibb announced results from True North, a pivotal Phase 3 trial evaluating oral Zeposia (ozanimod) as an induction and maintenance therapy for adult patients with moderate to severe ulcerative colitis.
True North acquires 3% stake in Biologics India for $100m pharmaceutical-technology
January 07, 2020
Private equity fund True North has acquired 3% stake in Biologics India (BBIL) for nearly $100m, reported The Economic Times.
Glenmark inks pact with True North for pain management biospectrumasia
August 13, 2018
The business is valued at Rs 6.35 bn and Glenmark will continue to hold a stake in the new company